BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9523118)

  • 1. Endosomal proteolysis and MHC class II function.
    Chapman HA
    Curr Opin Immunol; 1998 Feb; 10(1):93-102. PubMed ID: 9523118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
    Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
    J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsins and compartmentalization in antigen presentation.
    Riese RJ; Chapman HA
    Curr Opin Immunol; 2000 Feb; 12(1):107-13. PubMed ID: 10679409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
    Sevilla LM; Richter SS; Miller J
    Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endosomal proteases and antigen processing.
    Fineschi B; Miller J
    Trends Biochem Sci; 1997 Oct; 22(10):377-82. PubMed ID: 9357312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
    Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
    Moldenhauer G; Henne C; Karhausen J; Möller P
    Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II MHC peptide loading by the professionals.
    Bryant P; Ploegh H
    Curr Opin Immunol; 2004 Feb; 16(1):96-102. PubMed ID: 14734116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.
    Villadangos JA; Driessen C; Shi GP; Chapman HA; Ploegh HL
    EMBO J; 2000 Mar; 19(5):882-91. PubMed ID: 10698930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation.
    Medd PG; Chain BM
    Semin Cell Dev Biol; 2000 Jun; 11(3):203-10. PubMed ID: 10906277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting.
    Bakke O; Nordeng TW
    Immunol Rev; 1999 Dec; 172():171-87. PubMed ID: 10631946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly, transport, and function of MHC class II molecules.
    Cresswell P
    Annu Rev Immunol; 1994; 12():259-93. PubMed ID: 8011283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology of antigen presentation.
    Neefjes JJ; Momburg F
    Curr Opin Immunol; 1993 Feb; 5(1):27-34. PubMed ID: 7680870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell biology of antigen processing and presentation.
    Brodsky FM; Guagliardi LE
    Annu Rev Immunol; 1991; 9():707-44. PubMed ID: 1910692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.